151 – 200 of 262
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).
(
- Contribution to journal › Article
-
Mark
Chapter 9: Evidence based pharmacy for developing countries
(
- Contribution to journal › Article
-
Mark
Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
(
- Contribution to journal › Scientific review
-
Mark
Chapter 12: Evidence-based skills and practices for the future of pharmacy
(
- Contribution to journal › Article
-
Mark
Molecularly Imprinted Polymer Nanocarriers for Sustained Release of Erythromycin.
(
- Contribution to journal › Article
-
Mark
Chapter 8: Generating knowledge
(
- Contribution to journal › Article
-
Mark
Virtual screening for identifying a putative inhibitor of rmlc, a major target protein in tuberculosis disease
(
- Contribution to journal › Article
- 2014
-
Mark
Opioids for Chronic Refractory Breathlessness: Right Patient, Right Route?
(
- Contribution to journal › Article
-
Mark
Chapter 6: How to best practice evidence-based pharmacy with your available resources?
(
- Contribution to journal › Article
-
Mark
Bioadhesive Lipid Compositions: Self-Assembly Structures, Functionality, and Medical Applications.
(
- Contribution to journal › Article
-
Mark
Epigenetic adaptation to regular exercise in humans.
(
- Contribution to journal › Scientific review
-
Mark
Medication beliefs and self-reported adherence-results of a pharmacist's consultation: a pilot study
(
- Contribution to journal › Article
-
Mark
The tools of evidence-based medicine
(
- Contribution to journal › Article
-
Mark
Chapter 5: Appraising the evidence
(
- Contribution to journal › Article
-
Mark
Results from a project to develop systematic patient focused clinical pharmacy services. The Lund Integrated Medicines Management model
(
- Contribution to journal › Article
-
Mark
Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse
(
- Contribution to journal › Article
-
Mark
CHAPTER 3: Asking and formulating the right questions and finding useful resources in evidence-based pharmacy-2nd edition
(
- Contribution to journal › Article
-
Mark
The rate and nature of medication errors among elderly upon admission to hospital after implementation of clinical pharmacist-led medication reconciliation
(
- Contribution to journal › Article
-
Mark
Polymorphism of Paracetamol: A New Understanding of Molecular Flexibility through Local Methyl Dynamics.
(
- Contribution to journal › Article
-
Mark
Chapter 7: Managing knowledge in evidence-based pharmacy
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
The Use of Central Nervous System Active Drugs During Pregnancy.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
(
- Contribution to journal › Article
-
Mark
Design of a Highly Selective and Potent Class of Non-planar Estrogen Receptor Agonists
(
- Contribution to journal › Article
-
Mark
CHAPTER 1 Ensuring pharmacy practice is fit for purpose in Evidence-based Pharmacy 2nd edition
(
- Contribution to journal › Scientific review
-
Mark
New Insights into the Carrier-Mediated Transport of Estrone-3-sulfate in the Caco-2 Cell Model
(
- Contribution to journal › Article
-
Mark
ApoLänk decreases patient medication discrepancies at discharge: initial experience from a Swedish bedside pharmacy service
(
- Contribution to journal › Article
-
Mark
CHAPTER 2 introduction to evidence-based practice in evidence-based pharmacy 2nd edition
(
- Contribution to journal › Article
-
Mark
Practicing evidence-based pharmacy
(
- Contribution to journal › Article
- 2012
-
Mark
The hospital LIMM-based clinical pharmacy service improves the quality of the patient medication process and saves time
(
- Contribution to journal › Article
-
Mark
Comparing Health Outcomes and Costs of General Vaccination with Pneumococcal Conjugate Vaccines in Sweden: A Markov Model
(
- Contribution to journal › Article
-
Mark
Clinical implementation of systematic medication reconciliation and review as part of the Lund Integrated Medicines Management model - impact on all-cause emergency department revisits.
(
- Contribution to journal › Article
-
Mark
Errors in medication history at hospital admission : Prevalence and predicting factors
(
- Contribution to journal › Article
- 2011
-
Mark
Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
(
- Contribution to journal › Article
-
Mark
Phosphatidylethanol in blood (B-PEth): A marker for alcohol use and abuse.
(
- Contribution to journal › Article
- 2010
-
Mark
Inhibition of Human DHODH by 4-Hydroxycoumarins, Fenamic Acids, and N-(Alkylcarbonyl)anthranilic Acids Identified by Structure-Guided Fragment Selection
(
- Contribution to journal › Article
-
Mark
Renal and cardiorespiratory effects of treatment with lactated Ringer's solution or physiologic saline (0.9% NaCl) solution in cats with experimentally induced urethral obstruction
(
- Contribution to journal › Article
- 2009
-
Mark
Colloidal Structures in Media Simulating Intestinal Fed State Conditions with and Without Lipolysis Products
(
- Contribution to journal › Article
-
Mark
Development of Novel Therapies in Murine Models for Gaucher Disease
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Treatment of acute pancreatitis: focus on medical care.
(
- Contribution to journal › Article
-
Mark
Synthesis and evaluation of dibenzothiazepines : A novel class of selective cannabinoid-1 receptor inverse agonists
(
- Contribution to journal › Article
- 2008
-
Mark
Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
(
- Contribution to journal › Article
-
Mark
Contribution of structural biology to clinically validated target proteins
(
- Contribution to journal › Article
-
Mark
Identification and characterization of novel small-molecule protease-activated receptor 2 agonists
(
- Contribution to journal › Article
-
Mark
Identification of the first synthetic steroidogenic factor 1 inverse agonists : Pharmacological modulation of steroidogenic enzymes
(
- Contribution to journal › Article
-
Mark
Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator
(
- Contribution to journal › Article
- 2007
-
Mark
Progress in miniaturisation of proteon arrays - a step closer to high-density nanoarrays
(
- Contribution to journal › Scientific review
-
Mark
AAPS-FDA workshop white paper: Microdialysis principles, application and regulatory perspectives
(
- Contribution to journal › Article
-
Mark
Structural development of self nano emulsifying drug delivery systems (SNEDDS) during In vitro lipid digestion monitored by small-angle x-ray scattering
(
- Contribution to journal › Article
-
Mark
Gene and Protein Expression of P-Glycoprotein, MRP1, MRP2, and CYP3A4 in the Small and Large Human Intestine.
(
- Contribution to journal › Article